UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 861177
NEW YORK, NY
Position in INDV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,988,004
+$7,943,808 QoQ
Shares Held
194,687
+13326.7% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 337 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 37%
Shared 0%
None 63%
Common Shares in INDV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $852,377,607 across 33 Drug Manufacturers - Specialty & Generic names. INDV ranks #10 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,924,988 | $282,049,632 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,832,465 | $129,843,910 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
218,164 | $118,207,795 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
504,233 | $84,983,427 | |
| 5 | VTRS |
Viatris Inc
|
4,293,757 | $68,184,856 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
482,743 | $53,555,505 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,510,327 | $37,169,144 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
425,977 | $14,768,619 |
All Filings in INDV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,988,004 | 194,687 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $44,196 | 1,450 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||